BioSyent (CVE:RX) Shares Cross Above 50-Day Moving Average - What's Next?

Key Points

• BioSyent Inc. shares recently crossed above their 50-day moving average of C$11.66, reaching a high of C$11.82 during trading.
• The company announced a quarterly dividend of $0.05 per share with a total annualized dividend of $0.20, representing a yield of 1.7%.
• BioSyent has a market cap of C$133.11 million and a PE ratio of 16.65, highlighting its stable growth potential in the healthcare market.

BioSyent Inc. (CVE:RX - Get Free Report)'s share price passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of C$11.66 and traded as high as C$11.82. BioSyent shares last traded at C$11.82, with a volume of 1,050 shares traded.

BioSyent Stock Performance

The business's 50-day moving average price is C$11.67 and its 200-day moving average price is C$11.36. The company has a current ratio of 3.92, a quick ratio of 6.91 and a debt-to-equity ratio of 2.90. The stock has a market cap of C$135.13 million, a PE ratio of 16.90 and a beta of 0.49.

BioSyent Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, September 15th. Shareholders of record on Friday, August 29th were given a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a yield of 1.7%. BioSyent's dividend payout ratio is presently 26.76%.

BioSyent Company Profile

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.